FTC commissioners zero in on whether LabMD harmed consumers
Well before the contentious battle between the Federal Trade Commission and LabMD reached the courtroom for oral arguments before the agency’s commissioners, Michael J. Daugherty, the medical company’s pugnacious CEO, was...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: